Christoph Engeler is a partner in the Hamburg office. Mr. Engeler practices in the firm’s Corporate Department, focusing on corporate and regulatory matters in the healthcare and life sciences industries. He has a wealth of experience advising domestic and international hospital and nursing home operators as well as financial investors in healthcare institutions on M&A transactions and restructurings. He further advises public authorities on privatizations of healthcare institutions and joint ventures. In the life sciences sector, Mr. Engeler advises German and foreign pharmaceuticals companies and manufacturers of medical devices on M&A transactions as well as German and EU regulatory matters, including clinical trials, manufacturing, marketing authorizations, distribution, promotion and marketing, interaction with healthcare professionals, vigilance, and reimbursement.
Mr. Engeler is consistently ranked for Health Care by Chambers Europe Germany: “Christoph Engeler has a growing reputation for life sciences work, focusing on regulatory issues relating to healthcare facilities. Sources highlight his ‘commitment to the sector’ and report that he is ‘very knowledgeable and client-oriented.’” (2015). Clients appreciate that he is “extremely responsive and able to turn things around quickly” and observe that Mr. Engeler “takes a practical approach to the matter at hand.” (Chambers Europe Germany 2016)
LMG Life Sciences 2014 recognizes: “Engeler often handles entire product life-cycles from development to market and was involved in an advisory capacity in one of the industries recent major deals (…).”